217 related articles for article (PubMed ID: 1542259)
1. Lovastatin inhibits low-density lipoprotein oxidation and alters its fluidity and uptake by macrophages: in vitro and in vivo studies.
Aviram M; Dankner G; Cogan U; Hochgraf E; Brook JG
Metabolism; 1992 Mar; 41(3):229-35. PubMed ID: 1542259
[TBL] [Abstract][Full Text] [Related]
2. Oxidized low density lipoprotein leads to macrophage accumulation of unesterified cholesterol as a result of lysosomal trapping of the lipoprotein hydrolyzed cholesteryl ester.
Maor I; Aviram M
J Lipid Res; 1994 May; 35(5):803-19. PubMed ID: 8071603
[TBL] [Abstract][Full Text] [Related]
3. Increased uptake of LDL by oxidized macrophages is the result of an initial enhanced LDL receptor activity and of a further progressive oxidation of LDL.
Fuhrman B; Judith O; Keidar S; Ben-Yaish L; Kaplan M; Aviram M
Free Radic Biol Med; 1997; 23(1):34-46. PubMed ID: 9165295
[TBL] [Abstract][Full Text] [Related]
4. Involvement of the macrophage low density lipoprotein receptor-binding domains in the uptake of oxidized low density lipoprotein.
Keidar S; Brook GJ; Rosenblat M; Fuhrman B; Dankner G; Aviram M
Arterioscler Thromb; 1992 Apr; 12(4):484-93. PubMed ID: 1373074
[TBL] [Abstract][Full Text] [Related]
5. Oxidized LDL increase free cholesterol and fail to stimulate cholesterol esterification in murine macrophages.
Roma P; Catapano AL; Bertulli SM; Varesi L; Fumagalli R; Bernini F
Biochem Biophys Res Commun; 1990 Aug; 171(1):123-31. PubMed ID: 2393386
[TBL] [Abstract][Full Text] [Related]
6. Low density lipoprotein modification by cholesterol oxidase induces enhanced uptake and cholesterol accumulation in cells.
Aviram M
J Biol Chem; 1992 Jan; 267(1):218-25. PubMed ID: 1730591
[TBL] [Abstract][Full Text] [Related]
7. Enhanced in vitro oxidation of plasma lipoproteins derived from hypercholesterolemic patients.
Lavy A; Brook GJ; Dankner G; Ben Amotz A; Aviram M
Metabolism; 1991 Aug; 40(8):794-9. PubMed ID: 1861629
[TBL] [Abstract][Full Text] [Related]
8. The in vitro and ex vivo antioxidant properties, and hypolipidemic activity of CGP 2881.
Feldman DL; Mogelesky TC; Sharif R; Sawyer WK; Jeune M; Hu CW; Leonards KS; Prescott MF
Atherosclerosis; 1999 Jun; 144(2):343-55. PubMed ID: 10407495
[TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein E and lipoprotein lipase reduce macrophage degradation of oxidized very-low-density lipoprotein (VLDL), but increase cellular degradation of native VLDL.
Keidar S; Kaplan M; Rosenblat M; Brook GJ; Aviram M
Metabolism; 1992 Nov; 41(11):1185-92. PubMed ID: 1435289
[TBL] [Abstract][Full Text] [Related]
10. Lipoprotein composition and oxidative modification during therapy with gemfibrozil and lovastatin in patients with combined hyperlipidaemia.
Vázquez M; Zambón D; Hernández Y; Adzet T; Merlos M; Ros E; Laguna JC
Br J Clin Pharmacol; 1998 Mar; 45(3):265-9. PubMed ID: 9517370
[TBL] [Abstract][Full Text] [Related]
11. Macrophage uptake of oxidized LDL inhibits lysosomal sphingomyelinase, thus causing the accumulation of unesterified cholesterol-sphingomyelin-rich particles in the lysosomes. A possible role for 7-Ketocholesterol.
Maor I; Mandel H; Aviram M
Arterioscler Thromb Vasc Biol; 1995 Sep; 15(9):1378-87. PubMed ID: 7670952
[TBL] [Abstract][Full Text] [Related]
12. Intraperitoneal injection of platelet secretory products into mice increases macrophage uptake of oxidized low density lipoprotein.
Hussein O; Brook GJ; Aviram M
Isr J Med Sci; 1993 Aug; 29(8):453-9. PubMed ID: 8407271
[TBL] [Abstract][Full Text] [Related]
13. Platelet secretory products increase low density lipoprotein oxidation, enhance its uptake by macrophages, and reduce its fluidity.
Aviram M; Dankner G; Brook JG
Arteriosclerosis; 1990; 10(4):559-63. PubMed ID: 2369366
[TBL] [Abstract][Full Text] [Related]
14. Human serum paraoxonase (PON 1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants.
Aviram M; Rosenblat M; Billecke S; Erogul J; Sorenson R; Bisgaier CL; Newton RS; La Du B
Free Radic Biol Med; 1999 Apr; 26(7-8):892-904. PubMed ID: 10232833
[TBL] [Abstract][Full Text] [Related]
15. Uptake of type III hypertriglyceridemic VLDL by macrophages is enhanced by oxidation, especially after remnant formation.
Whitman SC; Miller DB; Wolfe BM; Hegele RA; Huff MW
Arterioscler Thromb Vasc Biol; 1997 Sep; 17(9):1707-15. PubMed ID: 9327767
[TBL] [Abstract][Full Text] [Related]
16. Dietary antioxidant inhibits lipoprotein oxidation and renal injury in experimental focal segmental glomerulosclerosis.
Lee HS; Jeong JY; Kim BC; Kim YS; Zhang YZ; Chung HK
Kidney Int; 1997 Apr; 51(4):1151-9. PubMed ID: 9083281
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory effects of rosa roxburghii tratt juice on in vitro oxidative modification of low density lipoprotein and on the macrophage growth and cellular cholesteryl ester accumulation induced by oxidized low density lipoprotein.
Zhang C; Liu X; Qiang H; Li K; Wang J; Chen D; Zhuang Y
Clin Chim Acta; 2001 Nov; 313(1-2):37-43. PubMed ID: 11694237
[TBL] [Abstract][Full Text] [Related]
18. Dual effect of lovastatin and simvastatin on LDL-macrophage interaction.
Aviram M; Keidar S; Brook GJ
Eur J Clin Chem Clin Biochem; 1991 Oct; 29(10):657-64. PubMed ID: 1764540
[TBL] [Abstract][Full Text] [Related]
19. Effect of lovastatin on lipoprotein fluidity in patients with hypercholesterolaemia.
Levy Y; Klein L; Aviram M; Brook GJ; Cogan U
Scand J Clin Lab Invest; 1992 Nov; 52(7):671-7. PubMed ID: 1455161
[TBL] [Abstract][Full Text] [Related]
20. Oxidized cholesterol in oxidized low density lipoprotein may be responsible for the inhibition of LPS-induced nitric oxide production in macrophages.
Liu SX; Chen Y; Zhou M; Wan J
Atherosclerosis; 1998 Jan; 136(1):43-9. PubMed ID: 9544730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
